Latest Headlines

  1. Cancer Is Striking Earlier - Superpower And GRAIL Are Partnering To Expand Early Detection 4/1/2026

    Superpower, the first all-in-one proactive health platform, announced a strategic partnership with GRAIL, Inc. (Nasdaq: GRAL) to bring members access to the Galleri® multi-cancer early detection (MCED) test.

  2. Breaking The PCR-Only Barrier: Dual 510(k) Clearance And CLIA-Waiver Establish FINDER As The First Molecular Point-Of-Care Platform With Multifunctional Capabilities 3/31/2026

    Baebies announced FDA 510(k) clearance and CLIA-waiver approval for the FINDER® Flu A&B/SARS-CoV-2 Test, an ultra-rapid RT-PCR assay on the FINDER platform.

  3. Thermo Fisher Scientific Launches Thermo Scientific Glacios 3 Cryo-TEM 3/31/2026

    Thermo Fisher Scientific, the world leader in serving science, today introduces a next-generation cryogenic transmission electron microscope (cryo-TEM) designed to help scientists understand structural biology with greater clarity — now accessible in more lab environments than ever before.

  4. LabConnect Launches SampleGISTICS® 2.0 To Digitize Clinical Trial Sample Capture 3/31/2026

    LabConnect, a global provider of central laboratory services and functional service provider solutions for clinical trials, today announced the launch of SampleGISTICS® 2.0, an application that enables clinical research sites to scan, record and transmit participant sample information.

  5. Takara Bio USA And Hamilton Company Partner To Automate NGS Library Preparation 3/30/2026

    Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., and Hamilton Company announced a development and co-marketing agreement to deliver integrated, automated next-generation sequencing (NGS) library preparation workflows to laboratories worldwide.

  6. Ataraxis AI Launches Ataraxis Breast CTX, The First Predictive AI Test Estimating Individualized Chemotherapy Benefit In Breast Cancer 3/30/2026

    Ataraxis AI, a frontier artificial intelligence (AI) research lab developing AI-powered tools for oncology, today announced Ataraxis Breast CTX, a new predictive capability within its Ataraxis Breast platform, designed to help estimate individualized chemotherapy benefit in breast cancer patients.

  7. Lunit, CellCarta Announce Strategic Collaboration To Accelerate AI-Enabled Digital Pathology For Companion Diagnostic Programs 3/30/2026

    Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, and CellCarta, a leading global contract research organization (CRO) laboratory to the biopharmaceutical industry, today announced a strategic partnership to accelerate adoption of AI-enabled digital pathology workflows across translational research, clinical trials and companion diagnostic (CDx) programs.

  8. Roche Receives FDA 510(k) Clearance For Cobas® C703 And Cobas® ISE Neo, Next-Generation Analytical Units Enhancing Efficiency And Capability For Laboratories 3/30/2026

    Roche announced today the U.S. Food and Drug Administration (FDA) 510(k) clearance of its newest analytical units – the cobas® c 703 and cobas® ISE neo.

  9. Scispot Launches Labforms™ To Capture External Lab Data As Structured, Audit-Ready Records 3/27/2026

    Scispot has launched Labforms, a form builder designed for life science labs that need to collect data from external partners and bring it directly into their internal systems.

  10. STEMart Expands Comprehensive Portfolio Of High-Performance Chromatography Columns For Precision Laboratory Separations 3/26/2026

    STEMart, a US-based provider of comprehensive services for all phases of medical device development, has announced the expansion of its product line with the launch of Chromatography Columns.